ATTO
Attovia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.55
+5.58%Margins
Gross margin
40.4%
EBITDA margin
-4915.2%
EBIT margin
-4974.7%
Net margin
-4490.9%
FCF margin
-4556.4%
-53.8%
Return on equity
-47.2%
Return on assets
-57.4%
Return on invested capital
0.01x
Asset turnover
-$59.2M
Cash from operations
$2.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026